Or Recurrent Solid Tumors
📧 Sign up to get email alerts when something new happens for Or Recurrent Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating eribulin mesilate with irinotecan in children with refractory or recurrent solid tumors has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 trial of talazoparib in advanced or recurrent solid tumors shows safety data and preliminary activity; results posted.